FDA Drug Application (089025) for PROPOXYPHENE COMPOUND 65 by TEVA

Back to FDA Applications sponsored by TEVA

Application Number089025
Product Number001
FormCAPSULE;ORAL
Dosage389MG;32.4MG;65MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePROPOXYPHENE COMPOUND 65
Active IngredientASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient ASPIRIN60
List of drugs with Active Ingredient CAFFEINE44
List of drugs with Active Ingredient PROPOXYPHENE HYDROCHLORIDE17


Back to FDA Applications sponsored by TEVA